Company overview
Basic information
Company name
INTELI GENERICS NORD, UAB
Company code
300581284
VAT code
LT100002513815
Registered address
Vilnius, Šeimyniškių g. 3, LT-09312
Registration date
2006-07-05
Company age: 20 y. 2 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.maxpharma.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Leasing of intellectual property and similar products, except copyrighted works
Ownership form
Private without foreign capital
UAB "INTELI GENERICS NORD"
Company code: 300581284
Address: Vilnius, Šeimyniškių g. 3, LT-09312
VAT code: LT100002513815
Download a detailed company report
Make confident decisions with all the information about INTELI GENERICS NORD, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
INTELI GENERICS NORD, UAB (company code 300581284) is an operational private limited liability company registered in 2006. It is classified as a private company within the national private non-financial companies sector and is managed by a CEO only. The company is owned through private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. It is a micro company. Its registered address is Vilnius, Šeimyniškiu g. 3, LT-09312, in Vilnius city municipality and Vilnius county.
The company’s main activity is EVRK code O.77.40.00, leasing of intellectual property and similar products, except copyrighted works. The share capital is €2.9K. In 2025, the company generated revenue of €421.4K and net profit of €122.3K, with a profit margin of 29.0%. Revenue was slightly lower than in 2024, when it reached €431.1K, but remained above the 2023 level of €369.7K. Net profit also stayed positive across the period, following €153.1K in 2024 and €102.3K in 2023. Equity increased to €1.40M at the end of 2025, while liabilities were €58.0K and total assets €998.8K. The company averaged 3 employees in 2025 and still averaged 3 employees so far in 2026.
The company’s main activity is EVRK code O.77.40.00, leasing of intellectual property and similar products, except copyrighted works. The share capital is €2.9K. In 2025, the company generated revenue of €421.4K and net profit of €122.3K, with a profit margin of 29.0%. Revenue was slightly lower than in 2024, when it reached €431.1K, but remained above the 2023 level of €369.7K. Net profit also stayed positive across the period, following €153.1K in 2024 and €102.3K in 2023. Equity increased to €1.40M at the end of 2025, while liabilities were €58.0K and total assets €998.8K. The company averaged 3 employees in 2025 and still averaged 3 employees so far in 2026.